Greenwich Time

Price of atrial fibrillati­on med rises

- Keith Roach, M.D. Readers may email questions to: ToYourGood­Health@med .cornell.edu or mail questions to 628 Virginia Dr., Orlando, FL 32803.

Dear Dr. Roach: My husband is taking Eliquis for atrial fibrillati­on (AFib). The cost is going up, and there is no generic brand for Eliquis. Looking at drug websites, I have found other drugs that are anticoagul­ants: Xarelto, heparin and warfarin are a few. Is there a generic brand you would recommend that we can ask his doctor about to see if they will let him take that instead?

C.A.

Answer: Most people with AFib benefit from anticoagul­ants to reduce the risk of stroke. The vast majority of people with AFib without valvular disease will take either a direct-acting oral anticoagul­ant (DOAC) such as apixaban (Eliquis), dabigatran (Pradaxa), edoxaban (Savaysa), rivaroxaba­n (Xarelto) or warfarin (Coumadin).

Most experts choose one of the DOACs over warfarin because they have been proven to have lower risk of both stroke and major bleeding, compared with warfarin.

Also, warfarin has to be carefully monitored by blood testing of the clotting time. People with some types of heart valve disease (rheumatic mitral stenosis or a mechanical heart valve in particular) require warfarin therapy.

Generic forms of DOACs have been approved by the FDA, but are not available in pharmacies at the time of this writing.

Among the different DOACs, there is usually no strong reason to favor one over another beyond cost. The cost, however, varies widely among the different agents depending on insurance coverage, and you can ask your husband’s doctor if he could take a different medicine from Eliquis.

I looked on goodrx.com, and the costs vary tremendous­ly from $200/month to over $500/month (without insurance). Some people take additional medicines, which may interact with one or more of the DOACs, so that needs to be considered.

Warfarin is very inexpensiv­e, less than $5 per month, but has the disadvanta­ges of requiring frequent blood draws and a higher risk of both bleeding and stroke.

Heparin (including low molecular weight heparin) is almost never used for long-term treatment of AFib except during pregnancy.

Newspapers in English

Newspapers from United States